Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improved Xiaochuan Plaster for allergic rhinitis with lung-spleen qi deficiency
ChiCTR2300071338Phase 2Not yet recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Oct 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Xiao Chuan Gao in allergic rhinitis (AR) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Visual analogue scale rating, Four nasal symptoms and 1 more. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
Xiao Chuan Gao
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR2300071338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071338.